AngioDynamics Inc. (ANGO)
-NasdaqGS 10.71 
0.04(0.37%) May 24, 4:00PM EDT
| Prev Close: | 10.67 |
|---|
| Open: | 10.64 |
|---|
| Bid: | 0.43 x 100 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 12.38 |
|---|
| Beta: | 0.71 |
|---|
| Next Earnings Date: | 8-Jul-13 |
|---|
| Day's Range: | 10.54 - 10.75 |
|---|
| 52wk Range: | 9.52 - 12.91 |
|---|
| Volume: | 66,241 |
|---|
| Avg Vol (3m): | 121,681 |
|---|
| Market Cap: | 373.77M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.21 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Tue, May 21)
- Taking a Closer Look at Medical Device and Product Companies, as Some are Generating High ROIs and Significant Free Cash Flow YieldsWall Street Transcript(Fri, May 17)
- A Comprehensive Overview Of Active Electroporation Cancer Trialsat Seeking Alpha(Tue, May 14)
- AngioDynamics to Present at UBS Global Healthcare ConferenceGlobeNewswire(Tue, May 14)
- ANGIODYNAMICS INC FinancialsEDGAR Online Financials(Sat, Apr 13)
- Weekly Market Wrap: April 12, 2013at Forbes(Fri, Apr 12)
- Biolitec CEO Neuberger Ordered Arrested by U.S. Judgeat Bloomberg(Fri, Apr 12)
- AngioDynamics Misses on Revenues but Beats on EPSat Motley Fool(Thu, Apr 11)
- AngioDynamics Still Struggling To Get Back On Trackat Investopedia(Wed, Apr 10)
- Company News for April 10, 2013Zacks(Wed, Apr 10)
- Zep, AngioDynamics Announce Earningsat Forbes(Tue, Apr 9)
- ANGO Posts Dismal 3Q EarningsZacks(Tue, Apr 9)
- ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitEDGAR Online(Mon, Apr 8)
- AngioDynamics Management Discusses Q3 2013 Results - Earnings Call Transcriptat Seeking Alpha(Mon, Apr 8)
- AngioDynamics Reports Fiscal 2013 Third Quarter Financial ResultsGlobeNewswire(Mon, Apr 8)
Key Statistics
| Forward P/E (1 yr): | 28.95 |
|---|
| P/S (ttm): | 1.21 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(May-13)
: | 0.34 |
|---|
| Quarterly EPS Est
(May-13)
: | 0.06 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 2.09 |
|---|
Business Summary
AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company operates in two segments, Vascular and Oncology/Surgery.
View More